Mirabella Financial Services LLP Gilead Sciences, Inc. Transaction History

Mirabella Financial Services LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $278,645 - $315,991	3,803 New	3,803 $308,000
Q2 2023 Aug 07, 2023	BUY	$76.01 - $86.7 $3.55 Million - $4.04 Million	46,640 New	46,640 $3.59 Million
Q3 2022 Oct 26, 2022	BUY	$59.54 - $68.01 $7.67 Million - $8.76 Million	128,863 New	128,863 $7.95 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $283,610 - $356,591	-4,567 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $330,376 - $383,628	4,567 New	4,567 $351,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

Stay updated on Mirabella Financial Services LLP with notifications on news.